AI Proteins
Health
· Headquartered in USA 🇺🇸
Track AI Proteins
— get Health deals in free daily digest
Overview
Ai Proteins, a Boston-based biotech company utilizing artificial intelligence to develop de novo medicines, raised $41.5 million in Series A funding led by Mission BioCapital and Santé Ventures, with participation from existing investors. The funds will support the expansion of operations and R&D efforts.
Products
Loading...
Synthesising company profile
Reading press coverage to extract founders, customers, traction signals and competitive positioning…
Recent Announcements
Investors: Mission BioCapital, Santé Ventures
Ai Proteins, a Boston-based biotech company utilizing artificial intelligence to develop de novo medicines, raised $41.5 million in Series A funding led by Mission BioCapital and Santé Ventures, with participation from existing investors. The funds will support the expansion of operations and R&D efforts.